Literature DB >> 24608442

Compromised gut microbiota networks in children with anti-islet cell autoimmunity.

David Endesfelder1, Wolfgang zu Castell2, Alexandria Ardissone3, Austin G Davis-Richardson3, Peter Achenbach4, Michael Hagen2, Maren Pflueger4, Kelsey A Gano3, Jennie R Fagen3, Jennifer C Drew3, Christopher T Brown3, Bryan Kolaczkowski3, Mark Atkinson5, Desmond Schatz5, Ezio Bonifacio6, Eric W Triplett3, Anette-G Ziegler7.   

Abstract

The gut microbiome is suggested to play a role in the pathogenesis of autoimmune disorders such as type 1 diabetes. Evidence of anti-islet cell autoimmunity in type 1 diabetes appears in the first years of life; however, little is known regarding the establishment of the gut microbiome in early infancy. Here, we sought to determine whether differences were present in early composition of the gut microbiome in children in whom anti-islet cell autoimmunity developed. We investigated the microbiome of 298 stool samples prospectively taken up to age 3 years from 22 case children in whom anti-islet cell autoantibodies developed, and 22 matched control children who remained islet cell autoantibody-negative in follow-up. The microbiome changed markedly during the first year of life, and was further affected by breast-feeding, food introduction, and birth delivery mode. No differences between anti-islet cell autoantibody-positive and -negative children were found in bacterial diversity, microbial composition, or single-genus abundances. However, substantial alterations in microbial interaction networks were observed at age 0.5 and 2 years in the children in whom anti-islet cell autoantibodies developed. The findings underscore a role of the microbiome in the pathogenesis of anti-islet cell autoimmunity and type 1 diabetes.
© 2014 by the American Diabetes Association.

Entities:  

Mesh:

Year:  2014        PMID: 24608442     DOI: 10.2337/db13-1676

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  71 in total

Review 1.  Blood-based signatures in type 1 diabetes.

Authors:  Susanne M Cabrera; Yi-Guang Chen; William A Hagopian; Martin J Hessner
Journal:  Diabetologia       Date:  2015-12-23       Impact factor: 10.122

2.  Dietary intake of soluble fiber and risk of islet autoimmunity by 5 y of age: results from the TEDDY study.

Authors:  Andreas Beyerlein; Xiang Liu; Ulla M Uusitalo; Minna Harsunen; Jill M Norris; Kristina Foterek; Suvi M Virtanen; Marian J Rewers; Jin-Xiong She; Olli Simell; Åke Lernmark; William Hagopian; Beena Akolkar; Anette-G Ziegler; Jeffrey P Krischer; Sandra Hummel
Journal:  Am J Clin Nutr       Date:  2015-07-08       Impact factor: 7.045

Review 3.  Microbiota—implications for immunity and transplantation.

Authors:  Jonathan S Bromberg; W Florian Fricke; C Colin Brinkman; Thomas Simon; Emmanuel F Mongodin
Journal:  Nat Rev Nephrol       Date:  2015-05-12       Impact factor: 28.314

Review 4.  The crucial role of early-life gut microbiota in the development of type 1 diabetes.

Authors:  He Zhou; Lin Sun; Siwen Zhang; Xue Zhao; Xiaokun Gang; Guixia Wang
Journal:  Acta Diabetol       Date:  2020-07-25       Impact factor: 4.280

5.  Modulation of the immune system by the gut microbiota in the development of type 1 diabetes.

Authors:  James A Pearson; Andrew Agriantonis; F Susan Wong; Li Wen
Journal:  Hum Vaccin Immunother       Date:  2018-09-19       Impact factor: 3.452

6.  Alterations in Intestinal Microbiota Correlate With Susceptibility to Type 1 Diabetes.

Authors:  Aimon K Alkanani; Naoko Hara; Peter A Gottlieb; Diana Ir; Charles E Robertson; Brandie D Wagner; Daniel N Frank; Danny Zipris
Journal:  Diabetes       Date:  2015-06-11       Impact factor: 9.461

7.  Diabetes. Altered gut microbial networks linked to islet cell autoimmunity.

Authors:  Jennifer Sargent
Journal:  Nat Rev Endocrinol       Date:  2014-04-01       Impact factor: 43.330

8.  Gut microbial metabolites limit the frequency of autoimmune T cells and protect against type 1 diabetes.

Authors:  Eliana Mariño; James L Richards; Keiran H McLeod; Dragana Stanley; Yu Anne Yap; Jacinta Knight; Craig McKenzie; Jan Kranich; Ana Carolina Oliveira; Fernando J Rossello; Balasubramanian Krishnamurthy; Christian M Nefzger; Laurence Macia; Alison Thorburn; Alan G Baxter; Grant Morahan; Lee H Wong; Jose M Polo; Robert J Moore; Trevor J Lockett; Julie M Clarke; David L Topping; Leonard C Harrison; Charles R Mackay
Journal:  Nat Immunol       Date:  2017-03-27       Impact factor: 25.606

Review 9.  Modulation of Type 1 Diabetes Risk by the Intestinal Microbiome.

Authors:  Mikael Knip; Jarno Honkanen
Journal:  Curr Diab Rep       Date:  2017-09-23       Impact factor: 4.810

10.  Intestinal virome changes precede autoimmunity in type I diabetes-susceptible children.

Authors:  Guoyan Zhao; Tommi Vatanen; Lindsay Droit; Arnold Park; Aleksandar D Kostic; Tiffany W Poon; Hera Vlamakis; Heli Siljander; Taina Härkönen; Anu-Maaria Hämäläinen; Aleksandr Peet; Vallo Tillmann; Jorma Ilonen; David Wang; Mikael Knip; Ramnik J Xavier; Herbert W Virgin
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.